Minurin (Desmopressin Acetate)

Desmopressin, the active ingredient in Minurin, is an antidiuretic hormone analog presented as a sterile injectable solution for intramuscular, intravenous, or subcutaneous use. It is employed to manage central diabetes insipidus, nocturnal enuresis, and certain bleeding disorders such as hemophilia A and von Willebrand disease.

GNH USA supplies Minurin as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide. The company adheres to stringent quality standards and provides reliable logistics for global distribution. Customers benefit from consistent product availability and regulatory compliance support.

Desmopressin acts on the antidiuretic hormone pathway to control water balance and coagulation factor release.

Central diabetes insipidus: reduces polyuria by enhancing renal water reabsorption. Nocturnal enuresis: decreases nighttime urine production, improving sleep continuity. Hemophilia A: raises plasma factor VIII levels to aid clot formation. Von Willebrand disease: elevates von Willebrand factor, supporting platelet adhesion and reducing bleeding.

Desmopressin may cause a range of adverse reactions, varying from mild to severe.

Common Side Effects: - Headache - Nausea - Mild hyponatremia

Serious or Rare Side Effects: - Severe hyponatremia with seizures - Water intoxication and cerebral edema - Allergic reactions including anaphylaxis

When using Minurin, several safety measures should be observed.

Monitor serum sodium: check electrolytes regularly, especially in high‑risk patients. Adjust dose in renal impairment: reduced clearance may increase effect. Use caution in elderly: increased susceptibility to water retention. Avoid concomitant use with other antidiuretic agents: risk of hyponatremia. Contraindicated in known hypersensitivity to desmopressin. Store at room temperature: keep in original container, protect from moisture and light.

Desmopressin can interact with other medicines, requiring attention to avoid harmful effects.

Major Interactions (Avoid): - Carbamazepine: induces metabolism, reducing desmopressin efficacy. - Thiazide diuretics: potentiate antidiuretic effect, increasing hyponatremia risk. - Other antidiuretic agents (e.g., vasopressin analogues): additive water retention.

Moderate Interactions (Monitor Closely): - NSAIDs: may enhance antidiuretic action and affect renal handling. - ACE inhibitors or ARBs: can contribute to fluid balance changes. - Selective serotonin reuptake inhibitors (SSRIs): reported to increase hyponatremia risk.